Finding a way through a tight deal space
Leaders of WilmerHale’s life sciences practice share trends they see regarding acquisitions and initial public offerings.
Leaders of WilmerHale’s life sciences practice share trends they see regarding acquisitions and initial public offerings.
Still recovering from a market correction two years ago, and with a scarcity of attractive targets and ongoing macroeconomic uncertainty, the life sciences dealmaking space is in a state of flux.